Double versus single high-dose melphalan 200 mg/m(2) and autologous stem cell transplantation for multiple myeloma: a region-based study in 484 patients from the Nordic area

Autologous stem cell transplantation is still considered the standard of care in young patients with multiple myeloma (MM). This disease is the most common indication for high-dose therapy (HDT) supported by hematopoietic stem cell transplantation and much data support the benefit of this procedure....

Descripción completa

Detalles Bibliográficos
Autores principales: Björkstrand, Bo, Klausen, Tobias W., Remes, Kari, Gruber, Astrid, Knudsen, Lene M., Bergmann, Olav J., Lenhoff, Stig, Johnsen, Hans E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222243/
http://dx.doi.org/10.4081/hr.2009.e2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222243/
http://dx.doi.org/10.4081/hr.2009.e2

Ejemplares similares